Skip to main content
. 2023 Nov 29;13:21039. doi: 10.1038/s41598-023-48412-x

Table 2.

Evaluation of present and reported outcomes.

Ha Nuave 38 Nuave 35 Nuave [Present]
1 2.5745 2.57959 2.5736
5 2.3985 2.3998 2.3976
10 2.2569 2.25793 2.2570
15 1.7786 1.7797 1.7791